Frontiers in Microbiology (Dec 2022)

Antifungal susceptibility profiles and drug resistance mechanisms of clinical Candida duobushaemulonii isolates from China

  • Xin-Fei Chen,
  • Xin-Fei Chen,
  • Xin-Fei Chen,
  • Han Zhang,
  • Han Zhang,
  • Xin-Miao Jia,
  • Xin-Miao Jia,
  • Jin Cao,
  • Li Li,
  • Xin-Lan Hu,
  • Ning Li,
  • Yu-Ling Xiao,
  • Fei Xia,
  • Li-Yan Ye,
  • Qing-Feng Hu,
  • Xiao-Li Wu,
  • Li-Ping Ning,
  • Po-Ren Hsueh,
  • Po-Ren Hsueh,
  • Xin Fan,
  • Shu-Ying Yu,
  • Shu-Ying Yu,
  • Jing-Jing Huang,
  • Jing-Jing Huang,
  • Jing-Jing Huang,
  • Xiu-Li Xie,
  • Xiu-Li Xie,
  • Wen-Hang Yang,
  • Wen-Hang Yang,
  • Wen-Hang Yang,
  • Ying-Xing Li,
  • Ying-Xing Li,
  • Ge Zhang,
  • Ge Zhang,
  • Jing-Jia Zhang,
  • Jing-Jia Zhang,
  • Si-Meng Duan,
  • Si-Meng Duan,
  • Wei Kang,
  • Wei Kang,
  • Tong Wang,
  • Tong Wang,
  • Jin Li,
  • Jin Li,
  • Meng Xiao,
  • Meng Xiao,
  • Xin Hou,
  • Ying-Chun Xu,
  • Ying-Chun Xu

DOI
https://doi.org/10.3389/fmicb.2022.1001845
Journal volume & issue
Vol. 13

Abstract

Read online

Candida duobushaemulonii, type II Candida haemulonii complex, is closely related to Candida auris and capable of causing invasive and non-invasive infections in humans. Eleven strains of C. duobushaemulonii were collected from China Hospital Invasive Fungal Surveillance Net (CHIF-NET) and identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF), VITEK 2 Yeast Identification Card (YST), and internal transcribed spacer (ITS) sequencing. Whole genome sequencing of C. duobushaemulonii was done to determine their genotypes. Furthermore, C. duobushaemulonii strains were tested by Sensititre YeastOne™ and Clinical and Laboratory Institute (CLSI) broth microdilution panel for antifungal susceptibility. Three C. duobushaemulonii could not be identified by VITEK 2. All 11 isolates had high minimum inhibitory concentrations (MICs) to amphotericin B more than 2 μg/ml. One isolate showed a high MIC value of ≥64 μg/ml to 5-flucytosine. All isolates were wild type (WT) for triazoles and echinocandins. FUR1 variation may result in C. duobushaemulonii with high MIC to 5-flucytosine. Candida duobushaemulonii mainly infects patients with weakened immunity, and the amphotericin B resistance of these isolates might represent a challenge to clinical treatment.

Keywords